T cell targeted immunotherapy for autoimmune disease

Erica Lee; Animesh A. Sinha

doi:10.1080/08916930500418136

T cell targeted immunotherapy for autoimmune disease

Erica Lee
, Animesh A. Sinha

Department of Dermatology

Cornell University

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

Much emphasis has been placed on the so-called "biologics" in the treatment of immune disorders within the last few years. Here we discuss the expanding horizon of potential strategies for immunotherapies targeting T lymphocytes as key effectors and regulators of autoimmunity. We review emerging reagents in a variety of animal models and human disorders that may offer new therapeutic options in current or modified iterations.

Original language	English
Pages (from-to)	577-596
Number of pages	20
Journal	Autoimmunity
Volume	38
Issue number	8
DOIs	https://doi.org/10.1080/08916930500418136
State	Published - Dec 2005

Keywords

Autoimmune disease
Biologics
Immunotherapy
T cell

Access to Document

10.1080/08916930500418136

Cite this

@article{77e4e3719d84468bae525b5d2ba21868,

title = "T cell targeted immunotherapy for autoimmune disease",

abstract = "Much emphasis has been placed on the so-called {"}biologics{"} in the treatment of immune disorders within the last few years. Here we discuss the expanding horizon of potential strategies for immunotherapies targeting T lymphocytes as key effectors and regulators of autoimmunity. We review emerging reagents in a variety of animal models and human disorders that may offer new therapeutic options in current or modified iterations.",

keywords = "Autoimmune disease, Biologics, Immunotherapy, T cell",

author = "Erica Lee and Sinha, \{Animesh A.\}",

year = "2005",

month = dec,

doi = "10.1080/08916930500418136",

language = "English",

volume = "38",

pages = "577--596",

journal = "Autoimmunity",

issn = "0891-6934",

publisher = "Taylor and Francis Ltd.",

number = "8",

}

TY - JOUR

T1 - T cell targeted immunotherapy for autoimmune disease

AU - Lee, Erica

AU - Sinha, Animesh A.

PY - 2005/12

Y1 - 2005/12

N2 - Much emphasis has been placed on the so-called "biologics" in the treatment of immune disorders within the last few years. Here we discuss the expanding horizon of potential strategies for immunotherapies targeting T lymphocytes as key effectors and regulators of autoimmunity. We review emerging reagents in a variety of animal models and human disorders that may offer new therapeutic options in current or modified iterations.

AB - Much emphasis has been placed on the so-called "biologics" in the treatment of immune disorders within the last few years. Here we discuss the expanding horizon of potential strategies for immunotherapies targeting T lymphocytes as key effectors and regulators of autoimmunity. We review emerging reagents in a variety of animal models and human disorders that may offer new therapeutic options in current or modified iterations.

KW - Autoimmune disease

KW - Biologics

KW - Immunotherapy

KW - T cell

UR - https://www.scopus.com/pages/publications/30844473274

U2 - 10.1080/08916930500418136

DO - 10.1080/08916930500418136

M3 - Review article

C2 - 16390811

AN - SCOPUS:30844473274

SN - 0891-6934

VL - 38

SP - 577

EP - 596

JO - Autoimmunity

JF - Autoimmunity

IS - 8

ER -

T cell targeted immunotherapy for autoimmune disease

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this